Skip to main content
logo
TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
9.69
+0.02 (0.21%)
Sep 5, 2025, 1:30 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
New Drug Research and Development and Drug Sales
149.15M
Log In
Log In
Log In
Log In
Upgrade
New Drug Research and Development and Drug Sales Growth
25.18%
Log In
Log In
Log In
Log In
Upgrade
Other
1.50M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-62.34%
Log In
Log In
Log In
Log In
Upgrade
Other
1.50M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-62.34%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
Other
-
Log In
Log In
Log In
Log In
Upgrade
China
111.88M
Log In
Log In
Log In
Log In
Upgrade
China Growth
20.86%
Log In
Log In
Log In
Log In
Upgrade
Taiwan
38.78M
Log In
Log In
Log In
Log In
Upgrade
Taiwan Growth
26.84%
Log In
Log In
Log In
Log In
Upgrade
Russia
-
Log In
Log In
Log In
Log In
Upgrade
South Korea
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade